CLINICAL_TRIALS
trial_result
· 2025-06-26
Clinical Trial Update: Study of V117957 in Overactive Bladder Syndrome [Phase 1]
Summary
Phase 1 clinical trial of V117957 for overactive bladder syndrome has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imbrium Therapeutics | Conditions: Overactive Bladder Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2025-06-26